Ortoma AB Series B (ORT-B) - Total Liabilities
Based on the latest financial reports, Ortoma AB Series B (ORT-B) has total liabilities worth Skr18.63 Million SEK (≈ $2.00 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Ortoma AB Series B (ORT-B) cash flow conversion to assess how effectively this company generates cash.
Ortoma AB Series B - Total Liabilities Trend (2021–2025)
This chart illustrates how Ortoma AB Series B's total liabilities have evolved over time, based on quarterly financial data. See Ortoma AB Series B (ORT-B) net assets for net asset value and shareholders' equity analysis.
Ortoma AB Series B Competitors by Total Liabilities
The table below lists competitors of Ortoma AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
George Kent (Malaysia) Bhd
KLSE:3204
|
Malaysia | RM238.77 Million |
|
EYG Gayrimenkul Yatirim Ortakligi A.S.
IS:EYGYO
|
Turkey | TL758.51 Million |
|
Resource Mining Corporation Ltd
AU:RMI
|
Australia | AU$586.09K |
|
Acanthe Développement
PA:ACAN
|
France | €21.07 Million |
|
Medicamen Biotech Limited
NSE:MEDICAMEQ
|
India | Rs916.99 Million |
|
Orient Precision Industries Inc
KQ:065500
|
Korea | ₩60.62 Billion |
|
Yotta Acquisition Corporation Common Stock
NASDAQ:YOTA
|
USA | $8.47 Million |
|
Bubang Co. Ltd
KQ:014470
|
Korea | ₩81.19 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down Ortoma AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ORT-B market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ortoma AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ortoma AB Series B (2021–2025)
The table below shows the annual total liabilities of Ortoma AB Series B from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr18.63 Million ≈ $2.00 Million |
-2.35% |
| 2024-12-31 | Skr19.07 Million ≈ $2.05 Million |
+1.48% |
| 2023-12-31 | Skr18.80 Million ≈ $2.02 Million |
-49.23% |
| 2022-12-31 | Skr37.02 Million ≈ $3.98 Million |
+836.96% |
| 2021-12-31 | Skr3.95 Million ≈ $425.22K |
-- |
About Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more